Healthiness Of Actors In DTC Spots Returns As Issue As FDA Cites Aricept Ads

Pfizer, which co-markets the Alzheimer's treatment with Eisai, could feel the biggest impact of the notice of violation due to its settlement with state attorneys general.

More from Archive

More from Pink Sheet